27 lectures · 147 items
6 min
11 min
17 min
16 min
37 min
16 min
10 min
19 min
7 min
18 min
1 min
10 min
EU Screening Week - Know Your Numbers Campaign
Atlas of Cardiology - Avoidable inequalities remain in cardiovascular disease burden and care 
Towards Comprehensive Cardiovascular Health Checks accross Europe
Heart failure is common in people with atrial fibrillation detected during screening
EU NextGen project advances personalised cardiology by integrating genomic and clinical data into AI models
AI-Digital Stethoscopes Outperform Traditional Screening for Significant VHD
Stroke identified as the second leading cause of death from cardiovascular disease and a major contributor of acquired long-term disability
EU Launches Ambitious "Safe Hearts Plan": A New Roadmap in Cardiovascular Health
Tackling the Enduring Cardiovascular Impact of COVID-19: New Guidance for Primary Care
GPcardio and ACC’s NCD Academy Join Forces to Strengthen Primary Care in Cardiovascular Disease Prevention
Sex Differences and Trends in Cardiovascular Risk Management: Insights from a Long-Term Primary Care Study
Primary Prevention of Atherosclerotic Cardiovascular Disease (ASCVD) in Primary care: A Systematic Review of Guidelines
Study on Cardiovascular Risk Factors and Primary Care Utilization in Spain
The Vital Role of Primary Care in Advancing Cardiovascular Health
Gamification and financial incentives to increase physical activity among patients at elevated CV risk
Slides | Take home messages of EPCCS Guidance on 'Current management of diabetes and CV risk in primary care'retatrutide yields up to 18.8 percent weight loss and a 10.8 mmHg lower systolic blood pressure in obesity with type 2 diabetes, with hypotension and dysesthesia as new signals
Presented at EASD 2026 in Milan and published simultaneously in The Lancet. TRIUMPH-2 randomised 1,152 adults with obesity or overweight (BMI 27 or higher, mean 38.2) and type 2 diabetes (mean HbA1c…
CagriSema lowers HbA1c by 0.16 points and weight by 4 points more than semaglutide in type 2 diabetes (REIMAGINE 2), zenagamtide follows
Amylin day at EASD 2026 in Milan. REIMAGINE 2 (Lancet Diabetes and Endocrinology) randomised 2,713 adults with type 2 diabetes on metformin with or without an SGLT2 inhibitor (mean HbA1c 8.2 percent…
retatrutide monotherapy lowers HbA1c by up to 1.1 percentage points more than placebo and body weight by up to 15 percent
Phase 3, double-blind trial in 537 adults with type 2 diabetes inadequately controlled on diet and exercise (mean HbA1c 7.9 percent, BMI 35.8, diabetes duration 2.5 years), randomised to once-weekly…
association, causality, and preventive potential.
A large prospective cohort study of nearly 500,000 UK Biobank participants, combined with bidirectional Mendelian randomization, evaluated 323 modifiable risk factors for ischemic stroke. Eighteen…
A COMBINE-AF Analysis.
A pooled analysis of five pivotal randomized trials (COMBINE-AF; n=73,737) demonstrates that extracranial bleeding occurs in 26% of patients with atrial fibrillation on oral anticoagulants over a…
1,300 ESC congress delegates measured, with excess weight in 47 percent, untreated hypertension and silent atherosclerosis in one in five
Cross-sectional health check of more than 1,300 healthcare professionals at ESC Congress 2025 with age- and sex-matched general-population controls. Excess weight 46.8 percent, hypertension 23.2…
imaging finds silent atherosclerosis in 57 percent of 16,808 adults without heart disease, and SCORE2 misses most of them
Prospective cross-sectional study in Denmark and Spain: 16,808 adults aged 18 to 70 without known cardiovascular disease, balanced by decade and sex, imaged with 3D vascular ultrasound of carotid and…
multidisciplinary, also home-based and digital, and for far more patients than the post-infarction group
Published today in the European Heart Journal ahead of its Monday presentation: the first dedicated ESC guideline on cardiac rehabilitation, chaired by Maria Bäck (Gothenburg), Matthias Wilhelm…
a randomised controlled trial.
Aligning the timing of exercise with chronotype ('morning' or 'evening' type) may yield greater cardiometabolic benefit. In this 12-week randomised trial (Lahore, Pakistan; 150 sedentary adults aged…
Cerebral amyloid angiopathy (CAA) — deposition of beta-amyloid in the brain's small vessels — is a major cause of haemorrhagic stroke and contributes to cognitive decline and to complications of…
Prospective cohort study in UK Biobank of 10,414 cancer survivors free of prior CVD who had completed ≥2 dietary recalls (mean age 59.5 years, 37% men). Over a median follow-up of 13.1 years, 1,331…
Emulation of a Target Trial.
Target trial emulation on US claims data (commercial + Medicare) of adults with type 2 diabetes and moderate cardiovascular risk who started canagliflozin (n=42,877), dapagliflozin (n=17,871), or…